e-Drug3D

2063

OMIDENEPAG

INN
OMIDENEPAG

cas 1187451-41-7

CLASS

SENSORY
SELECTIVE PROSTAGLANDIN E2 (EP2) RECEPTOR AGONIST
REDUCTION OF ELEVATED INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION

ROUTE (list)

ATC code

S01EX06

PK parameters

Target

TARGET PROSTAGLANDIN E2 (EP2) RECEPTOR

DrugCentral

Prostaglandin E2 receptor EP2 subtype UNIPROT P43116

Download SDF file

Glycine, N-[6-[[[[4-(1H-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]- (ACI)

Formula:
C23H22N6O4S

Calculated chemical properties:

MW 477.53
NB_atoms 34
XLogP 1.22
PSA 118.212
NB_HD 1
NB_HA 10
fsp3 0.13
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

2062

OMIDENEPAG ISOPROPYL

INN
OMIDENEPAG ISOPROPYL

(has an active metabolite)

cas 1187451-19-9

CLASS

SENSORY
SELECTIVE PROSTAGLANDIN E2 (EP2) RECEPTOR AGONIST
REDUCTION OF ELEVATED INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION

ROUTE (list)

OPHTHALMIC

ATC code

S01EX06

PK parameters

Solubility

PRACTICALLY INSOLUBLE IN WATER

Target

TARGET PROSTAGLANDIN E2 (EP2) RECEPTOR

DrugCentral

Prostaglandin E2 receptor EP2 subtype UNIPROT P43116 PTGER2

Download SDF file

Glycine, N-[6-[[[[4-(1H-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]-, 1-methylethyl ester (ACI)

Formula:
C26H28N6O4S

Calculated chemical properties:

MW 520.61
NB_atoms 37
XLogP 3.42
PSA 107.787
NB_HD 1
NB_HA 10
fsp3 0.23
Lipinski(0=no;1=yes) 0

FDA
NDA 215092 (label) INN (OMIDENEPAG ISOPROPYL) OMLONTI (OCUVEX THERAP) APPROVAL= AP YEAR= 2022 NEWMOLECULARENTITY